Lacey David L. has filed 9 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 31250 shares of Nurix Therapeutics, Inc. ($NRIX) on May 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Nurix Therapeutics, Inc. | $NRIX | Lacey David L. | Director | A | Director Stock Option (right to buy) | 31250 | $0.00 | 31,250.0000 | 102,843,012 | 9999.99% | 0.03% |
| June 10, 2025 | Arcus Biosciences, Inc. | $RCUS | Lacey David L. | Director | A | Stock Option (Right to Buy) | 38300 | $0.00 | 38,300.0000 | 105,841,422 | 9999.99% | 0.04% |
| June 10, 2025 | Arcus Biosciences, Inc. | $RCUS | Lacey David L. | Director | A | Common Stock | 13300 | $0.00 | 70,952.0000 | 105,841,422 | 23.07% | 0.01% |
| May 19, 2025 | Nurix Therapeutics, Inc. | $NRIX | Lacey David L. | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 75,886,817 | 9999.99% | 0.03% |
| Jan. 23, 2025 | Arcus Biosciences, Inc. | $RCUS | Lacey David L. | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Arcus Biosciences, Inc. | $RCUS | Lacey David L. | Director | A | Common Stock | 8400 | $0.00 | 57,652.0000 | 0 | 17.06% | 0.00% |
| June 6, 2024 | Arcus Biosciences, Inc. | $RCUS | Lacey David L. | Director | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2024 | Nurix Therapeutics, Inc. | $NRIX | Lacey David L. | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 54,337,901 | 9999.99% | 0.05% |
| May 4, 2023 | Nurix Therapeutics, Inc. | $NRIX | Lacey David L. | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 48,607,990 | 9999.99% | 0.05% |